- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05867927
GENERATE - Neste GENERASJON av gynekologisk kirurgi - Robotassistert kirurgi ved gynekologiske indikasjoner (GENERATE)
GENERATE - Neste GENERASJON av gynekologisk kirurgi - Robotassistert kirurgi i gynekologiske indikasjoner - En prospektiv, ikke-intervensjonell, multisenter, postmarkedsklinisk studie
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
Generate real-world evidence in the use of the da Vinci Surgical Systems for gynecological indications within the German health care system.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
A prospective, non-interventional, multi-center, post market clinical study.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Petra Kremer
- Telefonnummer: +49 151 62679136
- E-post: petra.kremer@intusurg.com
Studer Kontakt Backup
- Navn: Peter Appenrodt
- Telefonnummer: +49 173 2043740
- E-post: peter.appenrodt@intusurg.com
Studiesteder
-
-
-
Berlin, Tyskland, 13353
- Aktiv, ikke rekrutterende
- Charité - Universitätsmedizin Berlin - Klinik für Gynäkologie
-
Bochum, Tyskland, 44791
- Aktiv, ikke rekrutterende
- Augusta-Kranken-Anstalt Bochum
-
Coburg, Tyskland, 96450
- Aktiv, ikke rekrutterende
- Sana Kliniken Coburg
-
Cologne, Tyskland, 50935
- Avsluttet
- St. Elisabeth-Krankenhaus Köln-Hohenlind
-
Essen, Tyskland, 45147
- Aktiv, ikke rekrutterende
- Universitätsklinikum Essen
-
Frankfurt am Main, Tyskland, 60431
- Aktiv, ikke rekrutterende
- Agaplesion Markus Krankenhaus Frankfurt am Main
-
Freiburg im Breisgau, Tyskland, 79106
- Rekruttering
- Universitätsklinikum Freiburg - Klinik für Frauenheilkunde
-
Ta kontakt med:
- Markus Hübner, Prof. Dr.
-
Greifswald, Tyskland, 17475
- Rekruttering
- Universitätsmedizin Greifswald
-
Ta kontakt med:
- Zaher Alwafai, Dr.
- Telefonnummer: +49 3834 86 6500
- E-post: zaher.alwafai@med.uni-greifswald.de
-
Höxter, Tyskland, 37671
- Aktiv, ikke rekrutterende
- St. Ansgar Krankenhaus Höxter
-
Kiel, Tyskland, 24105
- Aktiv, ikke rekrutterende
- Universitätsklinikum Kiel
-
Nuremberg, Tyskland, 90419
- Aktiv, ikke rekrutterende
- Klinikum Nürnberg Nord / Klinik für Frauenheilkunde
-
Schwerin, Tyskland, 19055
- Aktiv, ikke rekrutterende
- Helios Kliniken Schwerin
-
Tübingen, Tyskland, 72076
- Aktiv, ikke rekrutterende
- Universitätsklinikum Tübingen - Frauenklinik
-
-
Free and Hanseatic City of Hamburg
-
Hamburg, Free and Hanseatic City of Hamburg, Tyskland, 22457
- Aktiv, ikke rekrutterende
- Albertinen Krankenhaus Hamburg
-
-
Hesse
-
Wiesbaden, Hesse, Tyskland, 65189
- Aktiv, ikke rekrutterende
- St. Josefs-Hospital Wiesbaden
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Patients with gynecological disease that may be treated by surgical intervention.
Beskrivelse
Key Inclusion Criteria:
- Woman with 18 years of age or older
- Patient is willing to participate and to comply with the study procedures as demonstrated by signing the informed consent
- Patient is a candidate for a gynecological procedure to be performed with the Intuitive Surgical System
Key Exclusion Criteria:
- Life expectancy of less than 1 year
- Pregnancy, or positive pregnancy test for women prior to menopause or breastfeeding women
- Current participation in a clinical study, if not pre-approved by Intuitive
- Individuals who are unable to fully understand all aspects of the study that are relevant to the decision to participate (mentally or verbally), or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliation
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
da Vinci Patients
Consecutive enrollment of patients with indications of interest and having a da Vinci robotic-assisted surgery |
Robotic-assisted surgery (da Vinci) |
|
Epidemiological Data Audit
Extended data collection on patients with indications of interest, eligible for a robotic-assisted surgery, but treatment choice was not a da Vinci surgery |
Non-da Vinci Surgery |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of complications related to the surgery up to 30 days
Tidsramme: 30 days
|
Describe the number of complications related to the surgery up to 30 days; adverse events as documented during the first 30 days will be classified as four different levels of causality to the surgery (not related, possible, probable and causal relationship). Descriptive analysis will be performed. |
30 days
|
|
Describe the number of patient-reported outcomes up to 12 months
Tidsramme: 12 months
|
Describe the patient-reported outcomes up to 12 months; descriptive analysis will be performed on the data directly reported via the patients (patient questionnaires); information included are number of complications, re-hospitalizations, re-operations, disease recurrence, disease remission, new disease diagnosis and pain status including pain medication |
12 months
|
|
Characterize the treatment decision as reported by the treating physician
Tidsramme: 30 days
|
Characterize the treatment decision per data provided by the treating physician (within the study database) including the rationale given for the treatment decision (e.g., age of the patient or co-morbidity); number of treatment decisions, e.g., for surgical therapy (open surgery or minimal-invasive therapy), watchful waiting, or treatment with medication will be described; descriptive analysis will be performed |
30 days
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Investigate the impact of patient characteristics on surgery
Tidsramme: 30 days
|
Descriptive analysis of patient characteristics such as age on surgery (e.g., duration of surgery, instrument usage) |
30 days
|
|
Investigate the impact of patient characteristics on clinical outcome
Tidsramme: 30 days
|
Descriptive analysis of patient characteristics such as age on clinical outcome (e.g., re-operation) |
30 days
|
|
Investigate the impact of patient characteristics on complications
Tidsramme: 30 days
|
Descriptive analysis of patient characteristics such as age on complication (number of complications reported during and after the surgery) |
30 days
|
|
Describe the impact from surgery to the patient's quality of life and function
Tidsramme: 12 months
|
Describe the impact from surgery to the patient's quality of life and function by comparing the baseline quality of life and functional status with the post-operative status (post-operative day 1-3, 30 days, 90 days, 6 months and 12 months) |
12 months
|
|
Describe the number of Intuitive instruments used per procedure and patient characteristics
Tidsramme: 30 days
|
Describe the number of Intuitive instruments used per procedure and patient characteristics; descriptive analysis will be performed on the number of instruments used per specific procedure and patient |
30 days
|
|
Describe the number of disease recurrence and re-operation at final patient follow-up
Tidsramme: 12 months
|
Describe the number disease recurrence and re-operation at final patient follow-up; descriptive analysis will be performed |
12 months
|
|
Describe the number of conversion per procedure and patient characteristics
Tidsramme: 30 days
|
Describe the number conversion per procedure and patient characteristics; descriptive analysis will be performed |
30 days
|
|
Describe the impact of surgeon experience on surgical times (duration of surgery per treating surgeon)
Tidsramme: 30 days
|
Describe the impact of surgeon experience on surgical times, descriptive analysis will be performed on the surgical times (duration of surgery) per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on clinical outcome (number of clinical outcomes per treating surgeon)
Tidsramme: 30 days
|
Describe the impact of surgeon experience on clinical outcome; descriptive analysis will be performed, e.g., on number of re-operation or re-hospitalization per treating surgeon |
30 days
|
|
Describe the impact of surgeon experience on complications (number of events per surgeon)
Tidsramme: 30 days
|
Describe the impact of surgeon experience on complications; descriptive analysis will be performed on number of adverse events per treating surgeon |
30 days
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Ingolf Juhasz-Böss, Prof. Dr., University Hospital Freiburg
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Urogenitale sykdommer
- Kjønnssykdommer
- Kvinnelige urogenitale sykdommer
- Kvinnelige urogenitale sykdommer og graviditetskomplikasjoner
- Kjønnssykdommer, kvinner
- Kirurgiske prosedyrer, operativ
- Teknologi, industri og landbruk
- Automasjon
- Teknologi
- Kirurgi, datamaskinassistert
- Robotikk
- Robotkirurgiske inngrep
Andre studie-ID-numre
- 114363C
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .